Clinical Trial Update: Ketamine in Bariatric Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the use of ketamine in bariatric surgery for patients with morbid obesity; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University of Padova | Conditions: Morbid Obesity | Phase 3 | Status: UNKNOWN